Rising prevalence of osteoporosis drives the vertebral compression fracture devices market
According to the International Osteoporosis Foundation estimates in 2010, osteoporosis affects 200 million people globally with approximate 9 million new osteoporotic fractures, with 1.6 million hip fractures, 1.7 million forearm fractures, and 1.4 million clinical vertebral fractures. The rising incidence of arthritis and osteoporosis, inability of medicinal therapy to cure vertebral compression fracture to the optimum level, and the advent of minimally invasive spine surgeries drives the growth of vertebral compression fracture devices market. Moreover, short recovery period, low risk of infection, limited hospital stay, and rise in geriatric population are projected to boost the demand for VCF devices globally. However, stringent regulatory approval process and the risk of post-surgical complications such as neurological injury and compromised pulmonary function are expected to restrain the market growth.
Balloon kyphoplasty devices segment is expected to procure largest revenue owing to its beneficial effects
The global vertebral compression fracture devices market is segmented on the basis of technology, diagnosis, surgery, end user, and geography.
On the basis of technology, the global vertebral compression fracture devices market is segmented into:
On the basis of diagnosis, the global vertebral compression fracture devices market is segmented into:
On the basis of surgery, the global vertebral compression fracture devices market is segmented into:
On the basis of end user, the global vertebral compression fracture devices market is segmented into:
Asia Pacific is projected to grow rapidly with the rise in healthcare expenditures to cater the unmet medical needs
Regional segmentation of the global VCF market by Coherent Market Insights comprises North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. According to the World Health Organization estimates in 2015, vertebral compression fractures (VCF) are the common type of fragility fractures with 700,000 VCF cases per year in the U.S., with 30% postmenopausal women likely to experience humerus, hip, and spine fractures, thereby propelling the demand for innovative VCF devices. North America is expected to dominate the global market, owing to the surge in procedure volumes, rising prevalence of impairments, spinal disorders such as spinal stenosis, well-defined reimbursement policies, supportive economic base, and high awareness of VCF conditions and treatments available. Asia Pacific is projected to grow rapidly during the forecast period due to the improving healthcare infrastructures, increasing healthcare expenditures in the emerging economies such as China and India to cater the unmet medical needs and rise in general awareness.
Vertebral Compression Fracture Devices Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients